secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001213900-26-043577
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Director Jon Kuwahara resigns from Emmaus Life Sciences board
-------------------------------------------------------------

- Director Jon Kuwahara resigned from the board of Emmaus Life Sciences on April 13, 2026, effective April 15, 2026.
- Willis Lee remains Chairman and Chief Executive Officer of Emmaus Life Sciences.
- Emmaus Life Sciences has no securities registered under Section 12(b) of the Exchange Act and no trading symbol.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390026043577/0001213900-26-043577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390026043577/ea0286215-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-043577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer